MedTrace Logo

One Month Daily Wear Clinical Evaluation of New Prototype Contact Lenses in Habitual and Neophyte Contact Lens Wearers

NCT02081677 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-06-19

Study results available
· View outcomes & findings →

Summary

There will be four study lenses tested; one marketed lens, and three prototype study lenses. Subjects will be randomized to one of the four study lenses which will be worn in a daily wear modality, with a two week replacement.

Conditions

  • Visual Correction

Interventions

DEVICE

ACUVUE 2

worn in a daily wear modality; lenses will be replaced after 2 weeks

DEVICE

Prototype E1

worn in a daily wear modality; lenses will be replaced after 2 weeks

DEVICE

Prototype E2

worn in a daily wear modality; lenses will be replaced after 2 weeks

DEVICE

Prototype E3

worn in a daily wear modality; lenses will be replaced after 2 weeks

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-06
Primary Completion
2014-06-25
Completion
2014-06-25
FDA Device
Yes

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02081677 on ClinicalTrials.gov